SMS HPV Vaccine Reminders

Completed · Not applicable

Conditions studied: Human Papillomavirus Vaccination

In brief

This study will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic, also in Kampala. While text messages can be used in populations with low literacy, families can opt to receive automated phone call reminders instead. The investigators will pilot assess the impact of vaccine reminders on human papillomavirus (HPV) vaccination. Caregivers of preteens/adolescents will be randomized and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). As this is a feasibility trial, the investigators expect to measure effect size but not necessarily achieve statistical significance.

Key facts

Study ID

NCT05151367

Run by

Columbia University

People needed

154

Starts

2022-02-23

Expected to finish

2022-12-31

Last updated by the study team

2024-07-08

Who can join

Age: 10 and older, up to 14. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Be a parenting adult of an adolescent girl aged 10-14 years
• Reside in Kampala and/or the surrounding districts
• Speak English or Luganda
• Have a cell phone with text messaging capability
• Must have ability to consent

You may not qualify if…

• Parenting adult speaks other language than English or Luganda only
• Parenting adult already enrolled in the study for another child
• Participation in pretesting activities

Where it is running

• Columbia University Irving Medical Center — New York, New York, United States
• Makerere University/Mulago Hospital — Kampala, Uganda

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.